Addiction and Deterrence@@@Psychopharmacology@@@Substance Abuse
Arwen Podesta, MD, ABPN, FASAM, ABIHM
Clinical Faculty at Tulane Psychiatry
Podesta Wellness
Tulane University
New Orleans, Louisiana
The Drug Addiction Treatment Act of 2000 enables clinicians to qualify to treat opioid dependency with buprenorphine products if they meet certain requirements and complete the necessary training. The use of medication-assisted treatment (MAT), such as buprenorphine, has proven to be an effective intervention, substantially reducing mortality and increasing retention in treatment. In this session, expert faculty will review what you need to know about buprenorphine training in order to help you determine whether or not it is something you want to explore.